Your browser doesn't support javascript.
loading
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide.
Potthoff, Anna-Laura; Heiland, Dieter Henrik; Evert, Bernd O; Almeida, Filipe Rodrigues; Behringer, Simon P; Dolf, Andreas; Güresir, Ági; Güresir, Erdem; Joseph, Kevin; Pietsch, Torsten; Schuss, Patrick; Herrlinger, Ulrich; Westhoff, Mike-Andrew; Vatter, Hartmut; Waha, Andreas; Schneider, Matthias.
Afiliación
  • Potthoff AL; Department of Neurosurgery, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. s4anpott@uni-bonn.de.
  • Heiland DH; Translational NeuroOncology Research Group, University of Freiburg, Breisacher Strasse 64, 79106 Freiburg im Breisgau, Germany. dieter.henrik.heiland@uniklinik-freiburg.de.
  • Evert BO; Faculty of Medicine, University of Freiburg, Breisacher Strasse 64, 79106 Freiburg im Breisgau, Germany. dieter.henrik.heiland@uniklinik-freiburg.de.
  • Almeida FR; Department of Neurosurgery, University of Freiburg, Breisacher Strasse 64, 79106 Freiburg im Breisgau, Germany. dieter.henrik.heiland@uniklinik-freiburg.de.
  • Behringer SP; Department of Neurology, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. b.evert@uni-bonn.de.
  • Dolf A; Department of Neuropathology, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. filipe.almeida@gmx.de.
  • Güresir Á; Translational NeuroOncology Research Group, University of Freiburg, Breisacher Strasse 64, 79106 Freiburg im Breisgau, Germany. simon.behringer@uniklinik-freiburg.de.
  • Güresir E; Faculty of Medicine, University of Freiburg, Breisacher Strasse 64, 79106 Freiburg im Breisgau, Germany. simon.behringer@uniklinik-freiburg.de.
  • Joseph K; Institute of Experimental Immunology, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. andreas.dolf@uni-bonn.de.
  • Pietsch T; Department of Neurosurgery, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. agi.gueresir@ukbonn.de.
  • Schuss P; Department of Neurosurgery, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. erdem.gueresir@ukbonn.de.
  • Herrlinger U; Translational NeuroOncology Research Group, University of Freiburg, Breisacher Strasse 64, 79106 Freiburg im Breisgau, Germany. kevin.joseph@uniklinik-freiburg.de.
  • Westhoff MA; Faculty of Medicine, University of Freiburg, Breisacher Strasse 64, 79106 Freiburg im Breisgau, Germany. kevin.joseph@uniklinik-freiburg.de.
  • Vatter H; Department of Neuropathology, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. torsten.pietsch@ukb.uni-bonn.de.
  • Waha A; Department of Neurosurgery, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. patrick.schuss@ukbonn.de.
  • Schneider M; Division of Clinical Neurooncology, Department of Neurology, Rheinische Friedrich-Wilhelms-University Hospital, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany. ulrich.herrlinger@ukbonn.de.
Cancers (Basel) ; 11(6)2019 Jun 20.
Article en En | MEDLINE | ID: mdl-31226836
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza